HER2 based subtyping of metastatic breast cancer: clinical and molecular characteristics

Sabine Heublein,Marc Zapatka,Mario Hlevnjak,Laura L. Michel,Katharina Smetanay,Carlo Fremd,Lars Buschhorn, Cindy Wagner,Hans‐Peter Sinn, Christian Freudlsperger,Peter Lichter,Andreas Schneeweiß,Verena Thewes

Senologie（2023）

引用 0|浏览7

暂无评分

摘要

Zielsetzung The question of whether HER2-low constitutes a distinct breast cancer (BC) sub-entity with specific clinical and molecular features remains unresolved.

查看译文

关键词

metastatic breast cancer,her2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要